296 related articles for article (PubMed ID: 28753127)
1. IGF2 mRNA binding protein-2 is a tumor promoter that drives cancer proliferation through its client mRNAs IGF2 and HMGA1.
Dai N; Ji F; Wright J; Minichiello L; Sadreyev R; Avruch J
Elife; 2017 Jul; 6():. PubMed ID: 28753127
[TBL] [Abstract][Full Text] [Related]
2. mTOR phosphorylates IMP2 to promote IGF2 mRNA translation by internal ribosomal entry.
Dai N; Rapley J; Angel M; Yanik MF; Blower MD; Avruch J
Genes Dev; 2011 Jun; 25(11):1159-72. PubMed ID: 21576258
[TBL] [Abstract][Full Text] [Related]
3. mTOR complex 2 phosphorylates IMP1 cotranslationally to promote IGF2 production and the proliferation of mouse embryonic fibroblasts.
Dai N; Christiansen J; Nielsen FC; Avruch J
Genes Dev; 2013 Feb; 27(3):301-12. PubMed ID: 23388827
[TBL] [Abstract][Full Text] [Related]
4. Imp2 regulates GBM progression by activating IGF2/PI3K/Akt pathway.
Mu Q; Wang L; Yu F; Gao H; Lei T; Li P; Liu P; Zheng X; Hu X; Chen Y; Jiang Z; Sayari AJ; Shen J; Huang H
Cancer Biol Ther; 2015; 16(4):623-33. PubMed ID: 25719943
[TBL] [Abstract][Full Text] [Related]
5. IMP2 Increases Mouse Skeletal Muscle Mass and Voluntary Activity by Enhancing Autocrine Insulin-Like Growth Factor 2 Production and Optimizing Muscle Metabolism.
Regué L; Ji F; Flicker D; Kramer D; Pierce W; Davidoff T; Widrick JJ; Houstis N; Minichiello L; Dai N; Avruch J
Mol Cell Biol; 2019 Apr; 39(7):. PubMed ID: 30692269
[TBL] [Abstract][Full Text] [Related]
6. p62/IMP2 stimulates cell migration and reduces cell adhesion in breast cancer.
Li Y; Francia G; Zhang JY
Oncotarget; 2015 Oct; 6(32):32656-68. PubMed ID: 26416451
[TBL] [Abstract][Full Text] [Related]
7. RNA m6A reader IMP2/IGF2BP2 promotes pancreatic β-cell proliferation and insulin secretion by enhancing PDX1 expression.
Regué L; Zhao L; Ji F; Wang H; Avruch J; Dai N
Mol Metab; 2021 Jun; 48():101209. PubMed ID: 33705986
[TBL] [Abstract][Full Text] [Related]
8. The Insulin-Like Growth Factor 2 mRNA Binding Protein IMP2/IGF2BP2 is Overexpressed and Correlates with Poor Survival in Pancreatic Cancer.
Dahlem C; Barghash A; Puchas P; Haybaeck J; Kessler SM
Int J Mol Sci; 2019 Jun; 20(13):. PubMed ID: 31261900
[TBL] [Abstract][Full Text] [Related]
9. IGF2 Is Up-regulated by Epigenetic Mechanisms in Hepatocellular Carcinomas and Is an Actionable Oncogene Product in Experimental Models.
Martinez-Quetglas I; Pinyol R; Dauch D; Torrecilla S; Tovar V; Moeini A; Alsinet C; Portela A; Rodriguez-Carunchio L; Solé M; Lujambio A; Villanueva A; Thung S; Esteller M; Zender L; Llovet JM
Gastroenterology; 2016 Dec; 151(6):1192-1205. PubMed ID: 27614046
[TBL] [Abstract][Full Text] [Related]
10. Elevated expression of the IGF2 mRNA binding protein 2 (IGF2BP2/IMP2) is linked to short survival and metastasis in esophageal adenocarcinoma.
Barghash A; Golob-Schwarzl N; Helms V; Haybaeck J; Kessler SM
Oncotarget; 2016 Aug; 7(31):49743-49750. PubMed ID: 27391348
[TBL] [Abstract][Full Text] [Related]
11. IGF2 mRNA binding protein p62/IMP2-2 in hepatocellular carcinoma: antiapoptotic action is independent of IGF2/PI3K signaling.
Kessler SM; Pokorny J; Zimmer V; Laggai S; Lammert F; Bohle RM; Kiemer AK
Am J Physiol Gastrointest Liver Physiol; 2013 Feb; 304(4):G328-36. PubMed ID: 23257922
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of HMGA1 deregulates tumor growth via cdc25A and alters migration/invasion through a cdc25A-independent pathway in medulloblastoma.
Lau KM; Chan QK; Pang JC; Ma FM; Li KK; Yeung WW; Cheng AS; Feng H; Chung NY; Li HM; Zhou L; Wang Y; Mao Y; Ng HK
Acta Neuropathol; 2012 Apr; 123(4):553-71. PubMed ID: 22249617
[TBL] [Abstract][Full Text] [Related]
13. miR-100 suppresses IGF2 and inhibits breast tumorigenesis by interfering with proliferation and survival signaling.
Gebeshuber CA; Martinez J
Oncogene; 2013 Jul; 32(27):3306-10. PubMed ID: 22926517
[TBL] [Abstract][Full Text] [Related]
14. RBM3 promotes neurogenesis in a niche-dependent manner via IMP2-IGF2 signaling pathway after hypoxic-ischemic brain injury.
Zhu X; Yan J; Bregere C; Zelmer A; Goerne T; Kapfhammer JP; Guzman R; Wellmann S
Nat Commun; 2019 Sep; 10(1):3983. PubMed ID: 31484925
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA IGF2-AS represses breast cancer tumorigenesis by epigenetically regulating IGF2.
Zhang Y; Yan H; Jiang Y; Chen T; Ma Z; Li F; Lin M; Xu Y; Zhang X; Zhang J; He H
Exp Biol Med (Maywood); 2021 Feb; 246(4):371-379. PubMed ID: 33175607
[TBL] [Abstract][Full Text] [Related]
16. HMGA1 regulates trabectedin sensitivity in advanced soft-tissue sarcoma (STS): A Spanish Group for Research on Sarcomas (GEIS) study.
Moura DS; Mondaza-Hernandez JL; Sanchez-Bustos P; Peña-Chilet M; Cordero-Varela JA; Lopez-Alvarez M; Carrillo-Garcia J; Martin-Ruiz M; Romero-Gonzalez P; Renshaw-Calderon M; Ramos R; Marcilla D; Alvarez-Alegret R; Agra-Pujol C; Izquierdo F; Ortega-Medina L; Martin-Davila F; Hernandez-Leon CN; Romagosa C; Salgado MAV; Lavernia J; Bagué S; Mayodormo-Aranda E; Alvarez R; Valverde C; Martinez-Trufero J; Castilla-Ramirez C; Gutierrez A; Dopazo J; Hindi N; Garcia-Foncillas J; Martin-Broto J
Cell Mol Life Sci; 2024 May; 81(1):219. PubMed ID: 38758230
[TBL] [Abstract][Full Text] [Related]
17. The HMGA2-IMP2 Pathway Promotes Granulosa Cell Proliferation in Polycystic Ovary Syndrome.
Li M; Zhao H; Zhao SG; Wei DM; Zhao YR; Huang T; Muhammad T; Yan L; Gao F; Li L; Lu G; Chan WY; Leung PCK; Dunaif A; Liu HB; Chen ZJ
J Clin Endocrinol Metab; 2019 Apr; 104(4):1049-1059. PubMed ID: 30247605
[TBL] [Abstract][Full Text] [Related]
18. Transgenic expression of the RNA binding protein IMP2 stabilizes miRNA targets in murine microsteatosis.
Dehghani Amirabad A; Ramasamy P; Wierz M; Nordström K; Kessler SM; Schulz MH; Simon M
Biochim Biophys Acta Mol Basis Dis; 2018 Oct; 1864(10):3099-3108. PubMed ID: 29859241
[TBL] [Abstract][Full Text] [Related]
19. CRNDE, a long non-coding RNA responsive to insulin/IGF signaling, regulates genes involved in central metabolism.
Ellis BC; Graham LD; Molloy PL
Biochim Biophys Acta; 2014 Feb; 1843(2):372-86. PubMed ID: 24184209
[TBL] [Abstract][Full Text] [Related]
20. LINC01021 maintains tumorigenicity by enhancing N6-methyladenosine reader IMP2 dependent stabilization of MSX1 and JARID2: implication in colorectal cancer.
Wu H; Ding X; Hu X; Zhao Q; Chen Q; Sun T; Li Y; Guo H; Li M; Gao Z; Yao W; Zhao L; Li K; Wei M
Oncogene; 2022 Mar; 41(13):1959-1973. PubMed ID: 35173309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
